X-linked Hypophosphatemia
📧 Sign up to get email alerts when something new happens for X-linked Hypophosphatemia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-08-28FDA Approved: CRYSVITA — Supplemental Application (Kyowa Kirin, Inc.)
FDA approved a supplemental application for CRYSVITA (burosumab) submitted by Kyowa Kirin, Inc. to update the product labeling. The document…